As a specialist in gastroenterology, internal medicine and hepatology, Dr. Hazan has used her expertise in many regards over the last two decades. Dr. Hazan is the founder & CEO of Progenabiome, a genetic sequencing research laboratory whose interest is to understand the clinical implications of the microbiome. Progenabiome has 42+ ongoing clinical trials investigating the microbiome and disease and six COVID-19 studies validating testing, prophylaxis, and treatment protocols for the novel coronavirus. It was the first lab to find the whole genome of SARS-CoV-2 in 100% of infected patients' stools.

Dr. Hazan is also the CEO of Ventura Clinical Trials, where she conducts and oversees clinical trials for cutting-edge research on various medical issues. She is a top clinical investigator for multiple pharmaceutical companies and has participated in over 300 clinical trials. She has also run a successful private practice, Malibu Specialty Center, for over 20 years.

Dr. Hazan acts as the series editor of Practical Gastroenterology on the microbiome, a peer review journal that reaches 18,000 gastroenterologists. She is a speaker for World Congress of Digestive Disease, MAGI, Microbiome Congress, International Drug Discovery Science and Technology Conference and NIST (National Institute of Standards and Technology).


This talk was part of Synchrony 2020 Online Symposium - 'From Bench to Biopharma', organised by the The BRAIN Foundation in partnership with UC Davis MIND Institute and CalTech.

For more Synchrony 2020 talks and highlights:    • Synchrony Symposium 2020 - From Bench...  

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

Synchrony https://synchronysymposium.com/ is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder.

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

The BRAIN Foundation https://brainfoundation.org/ is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care.

To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.